P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELIMINARY SAFETY RESULTS

Bibliographic Details
Main Authors:	J.-M. Sancho, A. Lopez-Guillermo, P. Abrisqueta, A. Kumar, R. Cordoba, M. Tani, W. Zhao, E. Rappold, P. Langmuir, M. Mims
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847276.06711.b7

Internet